Edition:
India

Valeant Pharmaceuticals International Inc (VRX.TO)

VRX.TO on Toronto Stock Exchange

28.54CAD
18 May 2018
Change (% chg)

$0.49 (+1.75%)
Prev Close
$28.05
Open
$28.29
Day's High
$28.69
Day's Low
$28.29
Volume
923,168
Avg. Vol
1,440,180
52-wk High
$30.56
52-wk Low
$14.01

Chart for

About

Valeant Pharmaceuticals International, Inc. is a pharmaceutical and medical device company. The Company is engaged in developing and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment,... (more)

Overall

Beta: -0.36
Market Cap(Mil.): $5,024.01
Shares Outstanding(Mil.): 347.33
Dividend: --
Yield (%): --

Financials

  VRX.TO Industry Sector
P/E (TTM): -- 30.95 32.75
EPS (TTM): -3.27 -- --
ROI: -2.83 14.84 14.38
ROE: -24.78 16.34 16.07

BRIEF-Valeant To Seek Refinancing Of Its Existing Credit Agreement

May 10 Valeant Pharmaceuticals International Inc :

10 May 2018

Valeant tries to leave the past behind with name change, shares surge

Valeant Pharmaceuticals International Inc said on Tuesday it will change its name to Bausch Health Companies Inc as it seeks to distance itself from a series of scandals and accounting issues under the drug company's previous management.

08 May 2018

UPDATE 3-Valeant tries to leave the past behind with name change, shares surge

May 8 Valeant Pharmaceuticals International Inc said on Tuesday it will change its name to Bausch Health Companies Inc as it seeks to distance itself from a series of scandals and accounting issues under the drug company's previous management.

08 May 2018

BRIEF-Valeant Reports Q1 Loss Per Share $7.68

May 8 Valeant Pharmaceuticals International Inc :

08 May 2018

BRIEF-Valeant Will Become Bausch Health Companies Inc

May 8 Valeant Pharmaceuticals International Inc :

08 May 2018

Valeant Pharma reports quarterly loss, to change name to Bausch Health

May 8 Valeant Pharmaceuticals International Inc reported first-quarter loss compared with a year-ago profit and said on Tuesday it would change its name to Bausch Health Companies Inc.

08 May 2018

Ex-Valeant executive's lawyers urge jury to reject fraud charge

NEW YORK A federal prosecutor told jurors in Manhattan on Thursday that a former Valeant Pharmaceuticals International Inc executive and the former head of mail order pharmacy Philidor Rx Services defrauded Valeant through a multimillion-dollar kickback scheme.

03 May 2018

UPDATE 1-Ex-Valeant exec's lawyers urge jury to reject fraud charge

NEW YORK, May 3 A federal prosecutor told jurors in Manhattan on Thursday that a former Valeant Pharmaceuticals International Inc executive and the former head of mail order pharmacy Philidor Rx Services defrauded Valeant through a multimillion-dollar kickback scheme.

03 May 2018

Ex-Valeant official accused of kickback scheme faces trial

NEW YORK, May 3 A former Valeant Pharmaceuticals International Inc executive and the former head of mail order pharmacy Philidor Rx Services will face trial Thursday on charges they orchestrated a multimillion-dollar kickback scheme, more than two years after Valeant drew scrutiny for its business practices.

03 May 2018

Competitors

Earnings vs. Estimates